Page last updated: 2024-10-22

aminoglutethimide and Growth Disorders

aminoglutethimide has been researched along with Growth Disorders in 2 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y1
Dabovic, B1
Colarossi, C1
Santori, FR1
Lilic, M1
Vukmanovic, S1
Rifkin, DB1
Cernich, J1
Jacobson, JD1
Moore, WV1
Popovic, J1

Reviews

1 review available for aminoglutethimide and Growth Disorders

ArticleYear
Use of aromatase inhibitors in children with short stature.
    Pediatric endocrinology reviews : PER, 2004, Volume: 2, Issue:1

    Topics: Adult; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Body Height; Child; Estrogens; Fema

2004

Other Studies

1 other study available for aminoglutethimide and Growth Disorders

ArticleYear
Growth retardation as well as spleen and thymus involution in latent TGF-beta binding protein (Ltbp)-3 null mice.
    Journal of cellular physiology, 2003, Volume: 196, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Aging; Aminoglutethimide; Animals; Carrier Proteins; Congenita

2003